We have approved
this one-time survey of medical device manufacturers as modified by
FDA on 12/1/93. We continue to urge that FDA or its contractor
undertake some sort of independent review of the self- reports of
medical device "significance." In addition, because the survey only
contacts firms that have recently obtained approval for their
devices, the survey does not present an unbiased sample for
policymaking purposes. Lack of a representative sample will prevent
F from making claims as to the overall effect of medical device
regulati on innovation within the industry.
Inventory as of this Action
Requested
Previously Approved
03/31/1994
03/31/1994
274
0
0
133
0
0
0
0
0
TO ASSESS THE IMPACT OF FDA
REGULATIONS REQUIRED BY THE SAFE MEDICAL DEVICES ACT, THE CURRENT
STATUS OF DEVICE INNOVATION IS NEEDED. A SURVEY OF INNOVATIVE
DEVICE ESTABLISHMENTS WILL ALLOW FDA TO ASSESS TH IMPACT OF
PROPOSED RULES BY EMPLOYMENT SIZE, SALES, AND CORPORATE STRUCTURE
PURSUANT TO E.O. 12291.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.